{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:16:12Z","timestamp":1793272572666,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.anai.2025.05.018","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T19:05:34Z","timestamp":1748027134000},"page":"303-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Establishing a hereditary angioedema prevalence for the United States using a large administrative claims database"],"prefix":"10.1016","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2641-3861","authenticated-orcid":false,"given":"Anthony J.","family":"Castaldo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen E.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhan","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emaan","family":"Rashidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine N.","family":"Selva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Corcoran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra C.","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Riedl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce L.","family":"Zuraw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilsa","family":"Loyo-Berrios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.anai.2025.05.018_bib0001","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1056\/NEJM199606203342510","article-title":"Agostoni A. Hereditary angioedema","volume":"334","author":"Cicardi","year":"1996","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.anai.2025.05.018_bib0002","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jaip.2020.08.046","article-title":"US HAEA Medical Advisory Board 2020 Guidelines for the management of hereditary angioedema","volume":"9","author":"Busse","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2025.05.018_bib0003","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000500196","article-title":"Hereditary angio-oedema for dermatologists","volume":"235","author":"Bygum","year":"2019","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.anai.2025.05.018_bib0004","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13223-021-00537-2","article-title":"Assessment and management of disease burden and quality of life in patients with hereditary angioedema: a consensus report","volume":"17","author":"Bork","year":"2021","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2025.05.018_bib0005","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.jaip.2021.03.008","article-title":"The expanding spectrum of mutations in hereditary angioedema","volume":"9","author":"Veronez","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.anai.2025.05.018_bib0006","article-title":"Hereditary angioedema with normal C1 inhibitor associated with carboxypeptidase N deficiency [published correction appears in J Allergy Clin Immunol Glob. 2024;3(4):100319]","volume":"3","author":"Vincent","year":"2024","journal-title":"J Allergy Clin Immunol Glob"},{"issue":"3","key":"10.1016\/j.anai.2025.05.018_bib0007","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jaci.2024.05.017","article-title":"DAB2IP associates with hereditary angioedema: insights into the role of VEGF signaling in HAE pathophysiology","volume":"154","author":"D\u2019Apolito","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.anai.2025.05.018_bib0008","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.jaip.2023.04.035","article-title":"A national survey of hereditary angioedema and acquired C1 Inhibitor deficiency in the United Kingdom","volume":"11","author":"Yong","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"suppl 1","key":"10.1016\/j.anai.2025.05.018_bib0009","doi-asserted-by":"crossref","first-page":"S08","DOI":"10.2500\/aap.2020.41.200050","article-title":"Hereditary angioedema: epidemiology and burden of disease","volume":"41","author":"Lumry","year":"2020","journal-title":"Allergy Asthma Proc"},{"issue":"3","key":"10.1016\/j.anai.2025.05.018_bib0010","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2500\/aap.2015.36.3824","article-title":"Current state of hereditary angioedema management: a patient survey","volume":"36","author":"Banerji","year":"2015","journal-title":"Allergy Asthma Proc"},{"issue":"4","key":"10.1016\/j.anai.2025.05.018_bib0011","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.anai.2016.08.014","article-title":"Misdiagnosis trends in patients with hereditary angioedema from the real-world clinical setting","volume":"117","author":"Zanichelli","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.anai.2025.05.018_bib0012","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13023-018-0815-5","article-title":"Epidemiology of bradykinin-mediated angioedema: a systematic investigation of epidemiological studies","volume":"13","author":"Aygoren-Pursun","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"10.1016\/j.anai.2025.05.018_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2024.100918","article-title":"Hereditary angioedema prevalence and satisfaction with prophylaxis in South Australia","volume":"17","author":"Troelnikov","year":"2024","journal-title":"World Allergy Organ J"},{"issue":"3","key":"10.1016\/j.anai.2025.05.018_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2024.100885","article-title":"Complex analysis of the national Hereditary angioedema cohort in Slovakia - Identification of 12 novel variants in SERPING1 gene","volume":"17","author":"Markocsy","year":"2024","journal-title":"World Allergy Organ J"},{"issue":"8","key":"10.1016\/j.anai.2025.05.018_bib0015","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1016\/j.jaip.2023.01.023","article-title":"Hereditary angioedema with normal C1 inhibitor: US survey of prevalence and provider practice patterns","volume":"11","author":"Riedl","year":"2023","journal-title":"J allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2025.05.018_bib0016","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2500\/aap.2020.41.200011","article-title":"Real-world cohort study of adult and pediatric patients treated for hereditary angioedema in the United States","volume":"41","author":"Tachdjian","year":"2020","journal-title":"Allergy Asthma Proc"},{"issue":"1","key":"10.1016\/j.anai.2025.05.018_bib0017","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13223-021-00541-6","article-title":"Leveraging unstructured data to identify hereditary angioedema patients in electronic medical records","volume":"17","author":"Brouwer","year":"2021","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.anai.2025.05.018_bib0018","unstructured":"Prescribing Cinryze: reimbursement. Accessed August 4, 2024. Available at: https:\/\/www.cinryze.com\/hcp\/reimbursement"},{"key":"10.1016\/j.anai.2025.05.018_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CLEP.S181242","article-title":"Measuring prevalence and incidence of chronic conditions in claims and electronic health record databases","volume":"11","author":"Rassen","year":"2019","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.anai.2025.05.018_bib0020","unstructured":"United States Census Bureau. Accessed June 14, 2023. Available at: https:\/\/www.census.gov\/"},{"key":"10.1016\/j.anai.2025.05.018_bib0021","unstructured":"Chapter 4. Prevalence calculation and interpretation. European network of population-based registries for the epidemiological surveillance of congenital anomalies (EUROCAT). Accessed August 4, 2024. Available at: https:\/\/eu-rd-platform.jrc.ec.europa.eu\/system\/files\/public\/eurocat\/Guide_1.5_Chapter_4.pdf"},{"issue":"3","key":"10.1016\/j.anai.2025.05.018_bib0023","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/jama.2021.24294","article-title":"Trends in US ambulatory care patterns during the COVID-19 pandemic, 2019-2021","volume":"327","author":"Mafi","year":"2022","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.anai.2025.05.018_bib0024","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.24984","article-title":"Changes in health services use among commercially insured US populations during the COVID-19 pandemic","volume":"3","author":"Whaley","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.anai.2025.05.018_bib0025","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.anai.2023.03.005","article-title":"Challenges in the management of hereditary angioedema in urban and rural settings: results of a United States survey","volume":"130","author":"Meadows","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2025.05.018_bib0026","unstructured":"Keisler-Starkey K, Bunch LN. Health insurance coverage in the United States. United States Census Bureau. Accessed August 4, 2024. Available at: https:\/\/www.census.gov\/content\/dam\/Census\/library\/publications\/2021\/demo\/p60-274.pdf"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120625002583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120625002583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T15:23:22Z","timestamp":1756740202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120625002583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1081120625002583"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2025.05.018","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishing a hereditary angioedema prevalence for the United States using a large administrative claims database","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2025.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}